Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

Other recent soundings have confirmed that Trump’s general approval rating is higher now than it was eight years ago — ...

The new administration is inheriting a robust economy and job market. Let’s compare in a year. Food prices are up due to documented corporate price gouging, so the promise of immediate lower pri ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

The weight loss field is projected to grow significantly through the end of the decade, while the U.S. Food and Drug Administration ... other medicines. In contrast to the single-product focus ...

Project 2025, the conservative governing playbook produced by veterans of the first Trump administration, has an entire ...

Erectile dysfunction (ED) is a common issue that affects millions of men, leading to a decline in quality of life and ...

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...